Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Rei Fujiki, Tomotaka Kawayama, Kyoji Furukawa, Takashi Kinoshita, Kazuko Matsunaga & Tomoaki Hoshino. (2023) The Efficacy and Safety of First-Line Single-Inhaler Triple versus Dual Therapy in Controller-Naïve and Symptomatic Adults with Asthma: A Preliminary Retrospective Cohort Study. Journal of Asthma and Allergy 16, pages 227-237.
Read now
Read now
Cristina Bassi Lourenco, Franco Martins, Elie Fiss & Anete Sevciovic Grumach. (2023) Impact of asthma control on quality of life in an outpatient setting in Brazil. Journal of Asthma 60:4, pages 794-801.
Read now
Read now
Hironori Sagara, Peter D’Andrea, Ana-Maria Tanase, Abhijit Pethe, Yukina Tanaka, Kazutaka Matsuo, Motoi Hosoe & Yoichi Nakamura. (2023) Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week studies. Journal of Asthma 60:2, pages 403-411.
Read now
Read now
Rei Fujiki, Tomotaka Kawayama, Kyoji Furukawa, Takashi Kinoshita, Kazuko Matsunaga & Tomoaki Hoshino. (2022) Daytime and Nighttime Visual Analog Scales May Be Useful in Assessing Asthma Control Levels Before and After Treatment. Journal of Asthma and Allergy 15, pages 1549-1559.
Read now
Read now
Keima Ito, Tomoko Tajiri, Hirono Nishiyama, Ryota Kurokawa, Jenifer Maries Go Yap, Norihisa Takeda, Kensuke Fukumitsu, Yoshihiro Kanemitsu, Satoshi Fukuda, Takehiro Uemura, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Masaya Takemura & Akio Niimi. (2022) Residual Dyspnea May Predict Small Airways Dysfunction and Poor Responsiveness to Single-Inhaler Triple Therapy in Asthmatic Patients. Journal of Asthma and Allergy 15, pages 1561-1568.
Read now
Read now
Takanori Numata, Jun Araya, Hanae Miyagawa, Keitaro Okuda, Daisuke Takekoshi, Mitsuo Hashimoto, Shunsuke Minagawa, Takeo Ishikawa, Hiromichi Hara & Kazuyoshi Kuwano. (2022) Real-World Effectiveness of Dupilumab for Patients with Severe Asthma: A Retrospective Study. Journal of Asthma and Allergy 15, pages 395-405.
Read now
Read now
Soichiro Hozawa, Hiroyuki Ohbayashi, Michiko Tsuchiya, Yu Hara, Laurie A Lee, Takashi Nakayama, Jun Tamaoki, Andrew Fowler & Takanobu Nishi. (2021) Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study. Journal of Asthma and Allergy 14, pages 809-819.
Read now
Read now
Yoichi Nakamura, Soichiro Hozawa, Hironori Sagara, Hiroyuki Ohbayashi, Laurie A. Lee, Jodie Crawford, Jun Tamaoki, Takanobu Nishi & Andrew Fowler. (2021) Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study. Current Medical Research and Opinion 37:9, pages 1657-1665.
Read now
Read now
Hisamitsu Omori, Noritaka Higashi, Takeshi Nawa, Toshiki Fukui, Toshihiko Kaise & Takeo Suzuki. (2020) Chronic Cough and Phlegm in Subjects Undergoing Comprehensive Health Examination in Japan – Survey of Chronic Obstructive Pulmonary Disease Patients Epidemiology in Japan (SCOPE-J). International Journal of Chronic Obstructive Pulmonary Disease 15, pages 765-773.
Read now
Read now
Gábor Tomisa, Alpár Horváth, Zsuzsanna Szalai, Veronika Müller & Lilla Tamási. (2019) Prevalence and impact of risk factors for poor asthma outcomes in a large, specialist-managed patient cohort: a real-life study. Journal of Asthma and Allergy 12, pages 297-307.
Read now
Read now
Quinn Thibodeaux, Mary Patricia Smith, Karen Ly, Kristen Beck, Wilson Liao & Tina Bhutani. (2019) A review of dupilumab in the treatment of atopic diseases. Human Vaccines & Immunotherapeutics 15:9, pages 2129-2139.
Read now
Read now
Articles from other publishers (17)
Hiroyuki Nagase, Risako Ito, Moe Ishii, Hideki Shibata, Shintaro Suo, Isao Mukai, Shiyuan Zhang, Kieran J. Rothnie, Claire Trennery, Liza Yuanita & Takeo Ishii. (2023) Relationship Between Asthma Control Status and Health-Related Quality of Life in Japan: A Cross-Sectional Mixed-Methods Study. Advances in Therapy 40:11, pages 4857-4876.
Crossref
Crossref
Yasuo Shimizu, Chie Sugimoto & Hiroshi Wakao. (2023) Potential of MAIT cells to modulate asthma. Allergology International.
Crossref
Crossref
Keima Ito, Yoshihiro Kanemitsu, Takeshi Kamiya, Kensuke Fukumitsu, Norihisa Takeda, Tomoko Tajiri, Ryota Kurokawa, Hirono Nishiyama, Jennifer Yap, Satoshi Fukuda, Takehiro Uemura, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Masaya Takemura & Akio Niimi. (2023) Functional gastrointestinal disorders are associated with capsaicin cough sensitivity in severe asthma. Allergology International 72:2, pages 271-278.
Crossref
Crossref
Akio Niimi, Yoshihiro Kanemitsu, Tomoko Tajiri, Kazuya Sumi, Toshiaki Mikami & Norihiko Kondo. (2023)
Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid/long-acting β
2
-agonist therapy in patients with asthma: REACH study design
. ERJ Open Research 9:2, pages 00452-2022.
Crossref
Crossref
Soichiro Hozawa, Akira Kikuchi & Shotaro Maeda. (2023) Real-world evaluation of asthma reliever therapy among continuous users of asthma maintenance medication in Japan: A retrospective cohort study using a claims database. Respiratory Investigation 61:2, pages 164-171.
Crossref
Crossref
Jorge Sánchez, Andres Sánchez Biol, Marlon Múnera Biol, Elizabeth García & Juan-Felipe López. (2023) Immunoglobulin E and G autoantibodies against eosinophil proteins in children and adults with asthma and healthy subjects. World Allergy Organization Journal 16:2, pages 100742.
Crossref
Crossref
Yuji Tohda, Yoichi Nakamura, Takao Fujisawa, Motohiro Ebisawa, Jerome Msihid, Michel Djandji, Benjamin Ortiz, Juby A. Jacob-Nara, Yamo Deniz, Paul J. Rowe, Masato Ishida & Kazuhiko Arima. (2023) Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study. Allergology International 72:1, pages 89-99.
Crossref
Crossref
Rieko Kondo, Shotaro Maeda, Akira Kikuchi, Hiromichi Kiyono & Tohru Sato. (2022) Optimal follow-up period after switching to another inhaled corticosteroid/long-acting β2 agonist in patients with asthma: A retrospective study using Japanese administrative claims data. PLOS ONE 17:10, pages e0276001.
Crossref
Crossref
Temesgen Mulugeta, Teshale Ayele, Getandale Zeleke & Gebremichael Tesfay. (2022) Asthma control and its predictors in Ethiopia: Systematic review and meta-analysis. PLOS ONE 17:1, pages e0262566.
Crossref
Crossref
Alexandrosz Czira, Monica Turner, Amber Martin, David Hinds, Helen Birch, Frances Gardiner & Shiyuan Zhang. (2022) A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma. Respiratory Medicine 191, pages 106670.
Crossref
Crossref
Yasuhiro Gon, Naho Ohyanagi & Akihiro Kobayashi. (2021) The association between control level and self-reported treatment adherence across different treatment types in Japanese asthma patients. Respiratory Investigation 59:4, pages 454-463.
Crossref
Crossref
Marcello Cottini, Anita Licini, Carlo Lombardi, Diego Bagnasco, Pasquale Comberiati & Alvise Berti. (2021) Small airway dysfunction and poor asthma control: a dangerous liaison. Clinical and Molecular Allergy 19:1.
Crossref
Crossref
Ashraf AlzaabiMajdy IdreesNaser Behbehani & Fatima Salah. (2021) Patients' and physicians' attitudes and perception about asthma in the Gulf: A subset analysis from the Asthma Insights and Management Survey in the Gulf and Russia. Allergy and Asthma Proceedings 42:3, pages e77-e85.
Crossref
Crossref
Mario Castro, Edward Kerwin, David Miller, Andrew Pedinoff, Lawrence Sher, Pamela Cardenas, Barbara Knorr, David Lawrence, Diego Ossa, Wei Wang & Jorge F Maspero. (2021) Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2). EClinicalMedicine 35, pages 100847.
Crossref
Crossref
Doan Thi Kim Cuc, Nonglak Methakanjanasak & Ho Thi Thuy Trang. (2021) Relationships between symptom control, medication management, and health literacy of patients with asthma in Vietnam. Belitung Nursing Journal 7:2, pages 131-138.
Crossref
Crossref
Hiromasa Inoue, Ki Lee Milligan, Aine McConnon, Hajime Yoshisue, Emil Loefroth, Martin McSharry, Akihito Yokoyama & Masakazu Ichinose. (2021) Uncontrolled asthma: a retrospective cohort study in Japanese patients newly prescribed with medium-/high-dose ICS/LABA. npj Primary Care Respiratory Medicine 31:1.
Crossref
Crossref
Raja Dhar, Mary Ip, Tarang Kulkarni, Sang‐Heon Kim, Diahn‐Warng Perng, Xin Yao, Takashi Iwanaga & Mariko Siyue Koh. (2020) Challenges faced in managing adult asthma: A perspective from Asian countries. Respirology 25:12, pages 1235-1242.
Crossref
Crossref